Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference11 articles.
1. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP). Module V—risk management systems. London: EMA; 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129134.pdf . Accessed 12 May 2016.
2. Vermeer NS, Duijnhoven RG, Straus SM, Mantel-Teeuwisse AK, Arlett PR, Egberts AC, Leufkens HG, De Bruin ML. Risk management plans as tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe. Clin Pharmacol Ther. 2014;96:723–31.
3. Raine J, Wise L, Blackburn S, Eichler HG, Breckenridge A. European perspective on risk management and drug safety. Clin Pharmacol Ther. 2011;89:650–4.
4. Waller P. Getting to grips with the new European Union pharmacovigilance legislation. Pharmacoepidemiol Drug Saf. 2011;20:544–9.
5. European Medicines Agency. One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency. London: EMA; 2014. http://ec.europa.eu/health/files/pharmacovigilance/2014_ema_oneyear_pharmacov_en.pdf . Accessed 12 May 2016.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献